INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹407 Cr | ₹337 Cr | ₹266 Cr | ₹165 Cr | ₹149 Cr |
What is the latest Consolidated Net Profit of INDEGENE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹407 Cr |
| Mar2024 | ₹337 Cr |
| Mar2023 | ₹266 Cr |
| Mar2022 | ₹165 Cr |
| Mar2021 | ₹149 Cr |
How is Consolidated Net Profit of INDEGENE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹407 Cr | 20.79 | |
| Mar2024 | ₹337 Cr | 26.53 | |
| Mar2023 | ₹266 Cr | 61.51 | |
| Mar2022 | ₹165 Cr | 10.28 | |
| Mar2021 | ₹149 Cr | - | |
Compare Consolidated Net Profit of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,778.8 Cr | -0.3% | 10.3% | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -0.3% |
10.3% |
-9.9% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses